SRA's number for the day: 204
This article was originally published in SRA
The report, minutes and oral and written evidence that a UK parliamentary committee published on 17 September on the shortcomings of the clinical trials environment run to 204-pages1,2.
You may also be interested in...
Autolus, Scholar Rock, Rocket and Pfizer have managed to convince the European Medicines Agency that their investigational treatments merit a place on the regulator’s priory medicines scheme.
Companies operating in New Zealand will have six months to transition to Medsafe’s updated code on good manufacturing practice.
Alexion is collecting more evidence to convince NICE that its anticoagulant reversal agent is also cost-effective for intracranial hemorrhage.